WMWei Ma

Wei Ma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Wei Ma has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Density and treatment effect estimation under covariate-adaptive randomization with heavy-tailed outcomes

    by Hongzi Li, Wei Ma, Yingying Ma, Hanzhong Liu

    Randomized experiments are the gold standard for investigating causal relationships, with comparisons of potential outcomes under different treatment groups used to estimate treatment effects. However, outcomes with heavy-tailed distributions pose significant challenges to traditional causal inference approaches. While recent studies have explored these issues under simple randomization, their application in more complex randomization designs, such as stratified randomization or covariate-adaptive randomization, has not been adequately addressed. To fill the gap, we first investigate the performance of nonparametric kernel density estimation methods under covariate-adaptive randomization, thereby establishing theoretical guarantees for treatment effect estimators based on the estimated densities. Second, we demonstrate the application of our density estimation framework to estimate the density treatment effect and overall quantile treatment effect, deriving the consistency and asymptotic normality of the estimators. For the overall quantile treatment effect, we show that the existing variance estimator for the influence function-based M-estimator tends to overestimate the asymptotic variance, especially under more balanced designs, and lacks universal applicability across randomization methods. To remedy this, we introduce a novel stratified transformed difference-in-means estimator to enhance efficiency and propose a universally applicable variance estimator to facilitate valid inferences. Numerical results demonstrate the effectiveness of the proposed methods in finite samples.

  • Efficient interaction analysis in randomized controlled trials

    by Likun Zhang, Wei Ma

    Identifying treatment-covariate interaction is an initial step toward revealing treatment effect heterogeneity and advancing precision medicine. However, when the covariate of interest is continuous, the definition of treatment-covariate interaction can be ambiguous or rely on questionable model assumptions. To tackle this challenge, we introduce a model-free framework for interaction analysis in randomized controlled trials, advocating the adoption of a clearly defined target parameter for interaction and thereby avoiding assumptions about the functional form of the data-generating mechanism. To ensure feasibility for most randomized controlled trials encountered in practice, we study interaction analysis under covariate-adaptive randomization, including simple and stratified randomization, and minimization methods. We observe that the usual method for interaction analysis can either exaggerate or understate uncertainty, leading to asymptotically conservative or anti-conservative results. We modify the usual method with a consistent variance estimator. Furthermore, by acknowledging the dependence structure of treatment assignment induced by covariate-adaptive randomization, we compute the semiparametric efficiency bound and introduce a novel semiparametric efficient method for analyzing our specified interaction effect. We demonstrate that our semiparametric efficient inference procedure, equipped with nonparametric and machine learning techniques for adjusting baseline covariate information, is both efficient and widely applicable.

  • Open Access

    Intrinsic capacity across the adult lifespan in China: baseline analysis from the nationwide longitudinal PENG ZU cohort

    by Ju Cui, Yujia Gu, Jing Pang, Huafang Gao, Li-Qun Zhang, Xiaolan Wu, Junwu Dang, Juan Li, Xinyi Zhu, Senlin Luo, et al.

    Intrinsic capacity (IC), a composite measure of physical and mental capacities, reflects the functional manifestations of biological aging, yet large-scale population evidence on how IC varies throughout adulthood outside Western settings remains limited. Using data from 17,086 Chinese adults aged 25-89 years in the nationally representative PENG ZU cohort, we characterized age-related variation in IC and its associated factors. IC was assessed across five domains (locomotion, cognition, vitality, psychological, sensory) using self-reported data and physical performance tests. A composite IC score was generated using weighted domain scores and standardized to a 0-100 range. IC levels declined progressively with age, with a sharper decrease and greater variability observed after age 60 in both sexes. The mean IC score was 67.8 (SD = 14) for participants aged < 60 years and 48.6 (SD = 17) for those aged ≥ 60 years. Inflection points were identified at age 60 for men and 62 for women, with significantly faster decline thereafter. The coefficient of variation in IC scores increased with age and differed significantly between adjacent age groups after 60 years. Among those aged ≥ 60, only 6.0% retained high IC, whereas nearly one-third experienced moderate-to-severe loss. Locomotion, cognition, vitality, and sensory domains showed marked age-related decline, with the largest reductions in cognition (60.7%), followed by locomotion (52.9%), vitality (51.0%), and sensory function (39.5%) between ages 50-54 and 85-89, while the psychological domain remained stable. Multivariate ANOVA identified age, education, and health consciousness (assessed via self-reported beliefs about personal responsibility for maintaining health) as the top factors associated with IC. Older age was associated with lower IC, whereas higher education and greater health consciousness were associated with higher IC. Furthermore, health consciousness was inversely associated with ADL/IADL disability across all age groups. These findings identify around 60 years as a critical window for the preservation of intrinsic capacity in Chinese adults and highlight health consciousness as a promising modifiable correlate that merits further investigation in the context of healthy aging.


  • Open Access

    Covariance-Driven Regression Trees: Reducing Overfitting in CART

    by Likun Zhang, Wei Ma

    Decision trees are powerful machine learning algorithms, widely used in fields such as economics and medicine for their simplicity and interpretability. However, decision trees such as CART are prone to overfitting, especially when grown deep or the sample size is small. Conventional methods to reduce overfitting include pre-pruning and post-pruning, which constrain the growth of uninformative branches. In this paper, we propose a complementary approach by introducing a covariance-driven splitting criterion for regression trees (CovRT). This method is more robust to overfitting than the empirical risk minimization criterion used in CART, as it produces more balanced and stable splits and more effectively identifies covariates with true signals. We establish an oracle inequality of CovRT and prove that its predictive accuracy is comparable to that of CART in high-dimensional settings. We find that CovRT achieves superior prediction accuracy compared to CART in both simulations and real-world tasks.


  • Open Access

    Assumption-lean covariate adjustment under covariate adaptive randomization when $p = o (n)$

    by Yujia Gu, Lin Liu, Wei Ma

    Adjusting for (baseline) covariates with working regression models becomes standard practice in the analysis of randomized clinical trials (RCT). When the dimension $p$ of the covariates is large relative to the sample size $n$, specifically $p = o (n)$, adjusting for covariates even in a linear working model by ordinary least squares can yield overly large bias, defeating the purpose of improving efficiency. This issue arises when no structural assumptions are imposed on the outcome model, a scenario that we refer to as the assumption-lean setting. Several new estimators have been proposed to address this issue. However, they focus mainly on simple randomization under the finite-population model, not covering covariate adaptive randomization (CAR) schemes under the superpopulation model. Due to improved covariate balance between treatment groups, CAR is more widely adopted in RCT; and the superpopulation model fits better when subjects are enrolled sequentially or when generalizing to a larger population is of interest. Thus, there is an urgent need to develop procedures in these settings, as the current regulatory guidance provides little concrete direction. In this paper, we fill this gap by demonstrating that an adjusted estimator based on second-order $U$-statistics can almost unbiasedly estimate the average treatment effect and enjoy a guaranteed efficiency gain if $p = o (n)$. In our analysis, we generalize the coupling technique commonly used in the CAR literature to $U$-statistics and also obtain several useful results for analyzing inverse sample Gram matrices by a delicate leave-$m$-out analysis, which may be of independent interest. Both synthetic and semi-synthetic experiments are conducted to demonstrate the superior finite-sample performance of our new estimator compared to popular benchmarks.


  • On the achievability of efficiency bounds for covariate-adjusted response-adaptive randomization

    by Jiahui Xin, Wei Ma

    In the context of precision medicine, covariate-adjusted response-adaptive (CARA) randomization has garnered much attention from both academia and industry due to its benefits in providing ethical and tailored treatment assignments based on patients’ profiles while still preserving favorable statistical properties. Recent years have seen substantial progress in inference for various adaptive experimental designs. In particular, research has focused on two important perspectives: how to obtain robust inference in the presence of model misspecification, and what the smallest variance, i.e., the efficiency bound, an estimator can achieve. Notably, Armstrong (2022) derived the asymptotic efficiency bound for any randomization procedure that assigns treatments depending on covariates and accrued responses, thus including CARA, among others. However, to the best of our knowledge, no existing literature has addressed whether and how this bound can be achieved under CARA. In this paper, by connecting two strands of adaptive randomization literature, namely robust inference and efficiency bound, we provide a definitive answer in an important practical scenario where only discrete covariates are observed and used for stratification. We consider a special type of CARA, i.e., a stratified version of doubly-adaptive biased coin design and prove that the stratified difference-in-means estimator achieves Armstrong (2022)’s efficiency bound, with possible ethical constraints on treatment assignments. Our work provides new insights and demonstrates the potential for more research on CARA designs that maximize efficiency while adhering to ethical considerations. Future studies could explore achieving the asymptotic efficiency bound for CARA with continuous covariates, which remains an open question.

  • Covariate-adjusted inference for doubly adaptive biased coin design

    by Fuyi Tu, Wei Ma

    Randomized controlled trials (RCTs) are pivotal for evaluating the efficacy of medical treatments and interventions, serving as a cornerstone in clinical research. In addition to randomization, achieving balances among multiple targets, such as statistical validity, efficiency, and ethical considerations, is also a central issue in RCTs. The doubly-adaptive biased coin design (DBCD) is notable for its high flexibility and efficiency in achieving any predetermined optimal allocation ratio and reducing variance for a given target allocation. However, DBCD does not account for abundant covariates that may be correlated with responses, which could further enhance trial efficiency. To address this limitation, this article explores the use of covariates in the analysis stage and evaluates the benefits of nonlinear covariate adjustment for estimating treatment effects. We propose a general framework to capture the intricate relationship between subjects’ covariates and responses, supported by rigorous theoretical derivation and empirical validation via simulation study. Additionally, we introduce the use of sample splitting techniques for machine learning methods under DBCD, demonstrating the effectiveness of the corresponding estimators in high-dimensional cases. This paper aims to advance both the theoretical research and practical application of DBCD, thereby achieving more accurate and ethical clinical trials.


  • Interaction Tests With Covariate‐Adaptive Randomization

    by Likun Zhang, Wei Ma

    Treatment‐covariate interaction tests are commonly applied by researchers to examine whether the treatment effect varies across patient subgroups defined by baseline characteristics. The objective of this study is to explore treatment‐covariate interaction tests involving covariate‐adaptive randomization. Without assuming a parametric data‐generating model, we investigate usual interaction tests and observe that they tend to be conservative: specifically, their limiting rejection probabilities under the null hypothesis are typically strictly lower than the nominal level. To address this problem, we propose modifications to the usual tests to obtain corresponding valid tests with limiting rejection probabilities equal to the nominal level. Moreover, we introduce a novel class of stratified‐adjusted interaction tests that are simple, more powerful than the usual and modified tests, and broadly applicable to most covariate‐adaptive randomization methods. The results encompass two types of interaction tests: one involving stratification covariates and the other involving additional covariates that are not used for randomization. Our study clarifies the application of interaction tests in clinical trials and offers valuable tools for revealing treatment heterogeneity, crucial for advancing personalized medicine.


  • Response‐Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints

    by Jingya Gao, Feifang Hu, Wei Ma

    In clinical trials, subjects are usually recruited sequentially. According to the outcomes amassed thus far in a trial, the response‐adaptive randomization (RAR) design has been shown to be an advantageous treatment assignment procedure that skews the treatment allocation proportion to pre‐specified objectives, such as sending more patients to a more promising treatment. Unfortunately, there are circumstances under which very few data of the primary endpoints are collected in the recruitment period, such as circumstances relating to public health emergencies and chronic diseases, and RAR is thus difficult to apply in allocating treatments using available outcomes. To overcome this problem, if an informative surrogate endpoint can be acquired much earlier than the primary endpoint, the surrogate endpoint can be used as a substitute for the primary endpoint in the RAR procedure. In this paper, we propose an RAR procedure that relies only on surrogate endpoints. The validity of the statistical inference on the primary endpoint and the patient benefit of this approach are justified by both theory and simulation. Furthermore, different types of surrogate endpoint and primary endpoint are considered. The results reassure that RAR with surrogate endpoints can be a viable option in some cases for clinical trials when primary endpoints are unavailable for adaptation.


  • Open Access

    On the achievability of efficiency bounds for covariate-adjusted response-adaptive randomization

    by Jiahui Xin, Wei Ma

    In the context of precision medicine, covariate-adjusted response-adaptive randomization (CARA) has garnered much attention from both academia and industry due to its benefits in providing ethical and tailored treatment assignments based on patients' profiles while still preserving favorable statistical properties. Recent years have seen substantial progress in understanding the inference for various adaptive experimental designs. In particular, research has focused on two important perspectives: how to obtain robust inference in the presence of model misspecification, and what the smallest variance, i.e., the efficiency bound, an estimator can achieve. Notably, Armstrong (2022) derived the asymptotic efficiency bound for any randomization procedure that assigns treatments depending on covariates and accrued responses, thus including CARA, among others. However, to the best of our knowledge, no existing literature has addressed whether and how the asymptotic efficiency bound can be achieved under CARA. In this paper, by connecting two strands of literature on adaptive randomization, namely robust inference and efficiency bound, we provide a definitive answer to this question for an important practical scenario where only discrete covariates are observed and used to form stratification. We consider a specific type of CARA, i.e., a stratified version of doubly-adaptive biased coin design, and prove that the stratified difference-in-means estimator achieves Armstrong (2022)'s efficiency bound, with possible ethical constraints on treatment assignments. Our work provides new insights and demonstrates the potential for more research regarding the design and analysis of CARA that maximizes efficiency while adhering to ethical considerations. Future studies could explore how to achieve the asymptotic efficiency bound for general CARA with continuous covariates, which remains an open question.